| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 97.072 | 116.452 | 119.342 | 158.949 | 140.075 | 179.068 | 423.234 | 501.731 | 390.458 | 521.863 |
| Total Income - EUR | 97.072 | 116.979 | 119.342 | 158.949 | 140.075 | 179.238 | 423.855 | 501.989 | 397.665 | 526.462 |
| Total Expenses - EUR | 64.730 | 41.486 | 52.917 | 76.150 | 67.825 | 50.109 | 112.147 | 160.399 | 152.934 | 187.856 |
| Gross Profit/Loss - EUR | 32.342 | 75.493 | 66.425 | 82.799 | 72.251 | 129.129 | 311.707 | 341.590 | 244.731 | 338.606 |
| Net Profit/Loss - EUR | 27.167 | 70.914 | 65.205 | 81.210 | 70.850 | 124.789 | 307.469 | 336.571 | 240.769 | 285.511 |
| Employees | 0 | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Urologica Exclusiv Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 5.776 | 33.554 | 13.785 | 34.747 | 11.893 | 76 | 151.368 | 172.223 | 70.706 |
| Current Assets | 80.814 | 71.181 | 35.966 | 67.998 | 50.481 | 115.315 | 353.505 | 362.534 | 254.753 | 263.668 |
| Inventories | 0 | 0 | 4.843 | 0 | 0 | 0 | 46.292 | 9.751 | 680 | 0 |
| Receivables | 16.430 | 12.657 | 10.233 | 10.851 | 15.980 | 18.409 | 266.986 | 321.561 | 141.278 | 235.512 |
| Cash | 30.638 | 40.710 | 3.376 | 39.956 | 17.642 | 80.368 | 30.120 | 21.083 | 102.687 | 18.105 |
| Shareholders Funds | 75.752 | 70.968 | 65.258 | 81.261 | 70.900 | 124.839 | 307.518 | 336.619 | 283.102 | 285.559 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 5.062 | 5.990 | 4.262 | 522 | 14.328 | 2.370 | 46.063 | 177.283 | 139.249 | 48.816 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.624 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Urologica Exclusiv Med Srl